Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 524: | Line 524: | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Adult T cell leukemia/lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" + |Adult T cell leukemia/lymphoma | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 548: | Line 549: | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Anaplastic large cell lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" + |Anaplastic large cell lymphoma | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 573: | Line 575: | ||
! align="center" style="background:#DCDCDC;" + |[[Mycosis fungoides]] / [[Sézary syndrome]] | ! align="center" style="background:#DCDCDC;" + |[[Mycosis fungoides]] / [[Sézary syndrome]] | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* The [[tumor]] [[Cell (biology)|cells]] originate from [[memory T cells]] or [[skin]] homing [[CD4+ T cells]] expressing [[cutaneous]] [[lymphocyte]] [[antigen]] (CLA) | * Mature T-cell Lymphoma | ||
* The [[tumor]] [[Cell (biology)|cells]] originate from [[memory T cells]] or [[skin]] homing [[CD4+ T cells]] expressing [[cutaneous]] [[lymphocyte]] [[antigen]] (CLA) an<nowiki/>d [[chemokine]] [[receptors]] [[CCR4]]<nowiki/>and CCR7. | |||
* It is understood that cutaneous t cell lymphoma (maycosis fungoides, Sezary sydrome ) is the result of malignant T cell that derived from a mature CD41 CD45RO1 memory T cells. | * It is understood that cutaneous t cell lymphoma (maycosis fungoides, Sezary sydrome ) is the result of malignant T cell that derived from a mature CD41 CD45RO1 memory T cells. | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 611: | Line 614: | ||
! align="center" style="background:#DCDCDC;" + |Subcutaneous panniculitis-like T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Subcutaneous panniculitis-like T-cell lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 635: | Line 639: | ||
! align="center" style="background:#DCDCDC;" + |Hepatosplenic gamma-delta T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Hepatosplenic gamma-delta T-cell lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 659: | Line 664: | ||
! align="center" style="background:#DCDCDC;" + |Enteropathy-type intestinal T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Enteropathy-type intestinal T-cell lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 683: | Line 689: | ||
! align="center" style="background:#DCDCDC;" + |Extranodal T-cell lymphoma, nasal type | ! align="center" style="background:#DCDCDC;" + |Extranodal T-cell lymphoma, nasal type | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 707: | Line 714: | ||
! align="center" style="background:#DCDCDC;" + |Angioimmunoblastic T-cell lymphoma | ! align="center" style="background:#DCDCDC;" + |Angioimmunoblastic T-cell lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 731: | Line 739: | ||
! align="center" style="background:#DCDCDC;" + |Peripheral T-cell lymphoma, unspecified | ! align="center" style="background:#DCDCDC;" + |Peripheral T-cell lymphoma, unspecified | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Mature T-cell Lymphoma | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | |
Revision as of 19:33, 7 January 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | |||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | PT/PTT | Immunochemistry | Histopathology | Other | ||||||||||||||
Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | Hepatosplenomegaly | Other | WBC | Hb | Plt | |||||||||||||
HL | |||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||
NHL | |||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
|||||||||||||||||||||
Follicular lymphoma |
|
|
|
Only in 20% of patients: | + | + | ± | Nl |
|
+ | ↓ | ↓ | Nl to ↓ |
|
NA |
|
|
|
Lymph node biopsy |
| |||
Mantle cell lymphoma |
|
|
Abdominal distention |
|
+ |
|
|
↓ | Nl to ↓ |
|
|
|
|||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic
|
|
||||||||||||||
Category | Disease | Etiology | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | Hepatosplenomegaly | Other | WBC | Hb | Plt | PBS | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Gold standard | Associated findings | |
Burkitt lymphoma |
|
|
|
|
|||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
|||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
+ |
|
|
|
| |||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||
Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||
Adult T cell leukemia/lymphoma |
|
||||||||||||||||||||||
T cell lymphoma | Anaplastic large cell lymphoma |
|
|||||||||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma |
|
|||||||||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma |
|
||||||||||||||||||||||
Enteropathy-type intestinal T-cell lymphoma |
|
||||||||||||||||||||||
Extranodal T-cell lymphoma, nasal type |
|
||||||||||||||||||||||
Angioimmunoblastic T-cell lymphoma |
|
||||||||||||||||||||||
Peripheral T-cell lymphoma, unspecified |
|